- Develops analytical equipment that enables high-accuracy, real-time molecular measurement over an extended period of time
- Aims to improve the quality of life of patients and healthcare professionals by developing equipment for simultaneous analysis of multiple components, including blood, immediately and without pain
- Strengthens international competitiveness through open innovation with companies involved in electronics, pharmaceuticals, and other sectors
Our Portfolio
Atonarp Inc.
| Outline | Development, manufacture, and sales of analytical equipment |
|---|---|
| Website | |
| Industry | Electronic devices |
| Commercialization stage | Early stage |
Provided Support
| Authorized Investment | USD 7.5 million (maximum) ／ USD 8 million (maximum) |
|---|---|
| Announcement Date | July 19, 2016／August 22, 2019 |
| Investment Structure |